DOPAMINE

DOPAMINE was reported 3802 times

DOPAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE CEMENT IMPLANTATION SYNDROME 2 0.2500
1 HARLEQUIN SKIN REACTION 3 0.2000
2 ENZYME INDUCTION 7 0.1458
3 HEPATOSPLENOMEGALY NEONATAL 5 0.1190
4 SHOSHIN BERIBERI 3 0.1071
5 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE 4 0.1053
6 PANTOEA AGGLOMERANS INFECTION 5 0.0649
7 NEONATAL MULTI-ORGAN FAILURE 3 0.0600
8 NEONATAL PNEUMOTHORAX 3 0.0545
9 POSTHAEMORRHAGIC HYDROCEPHALUS 3 0.0517
10 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 18 0.0517
11 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 4 0.0476
12 OBSTRUCTIVE SHOCK 5 0.0459
13 PULMONARY HAEMORRHAGE NEONATAL 4 0.0435
14 NEWBORN PERSISTENT PULMONARY HYPERTENSION 12 0.0427
15 ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0408
16 CONGENITAL ANAEMIA 2 0.0392
17 FEVER NEONATAL 5 0.0382
18 EXTUBATION 3 0.0370
19 PH BODY FLUID ABNORMAL 5 0.0360
20 DEVICE PACING ISSUE 3 0.0353
21 CIRCULATORY FAILURE NEONATAL 2 0.0339
22 NEONATAL CARDIAC FAILURE 3 0.0333
23 NEONATAL ANURIA 3 0.0316
24 CARDIOACTIVE DRUG LEVEL BELOW THERAPEUTIC 2 0.0294
25 ATELECTASIS NEONATAL 3 0.0278
26 DRUG-DEVICE INTERACTION 3 0.0270
27 RENAL FAILURE NEONATAL 6 0.0270
28 CSF WHITE BLOOD CELL COUNT INCREASED 5 0.0262
29 CARDIO-RESPIRATORY ARREST NEONATAL 2 0.0256
30 ENTEROBACTER PNEUMONIA 4 0.0256
31 PO2 INCREASED 13 0.0256
32 RENAL ISCHAEMIA 14 0.0256
33 PHAEOCHROMOCYTOMA CRISIS 5 0.0236
34 RETINOPATHY OF PREMATURITY 12 0.0217
35 THROMBOCYTOPENIA NEONATAL 9 0.0214
36 ANAPHYLACTOID SYNDROME OF PREGNANCY 2 0.0208
37 POSTOPERATIVE RENAL FAILURE 3 0.0207
38 HYPERTROPHIC CARDIOMYOPATHY 32 0.0207
39 HYPERDYNAMIC LEFT VENTRICLE 5 0.0203
40 PCO2 INCREASED 14 0.0197
41 DRY GANGRENE 12 0.0189
42 INFUSION SITE INJURY 3 0.0170
43 CARDIAC ASSISTANCE DEVICE USER 6 0.0160
44 DECOMPENSATED HYPOTHYROIDISM 2 0.0148
45 HIV VIRAEMIA 3 0.0143
46 RENAL VESSEL DISORDER 3 0.0142
47 HYPERBILIRUBINAEMIA NEONATAL 8 0.0137
48 BRASH SYNDROME 18 0.0128
49 INCISION SITE PAIN 15 0.0128
50 LIMB AMPUTATION 5 0.0126
51 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 6 0.0123
52 BLOOD LUTEINISING HORMONE INCREASED 3 0.0122
53 MEAN ARTERIAL PRESSURE DECREASED 3 0.0119
54 CONGENITAL CORONARY ARTERY MALFORMATION 2 0.0118
55 SYSTOLIC DYSFUNCTION 12 0.0114
56 PNEUMATOSIS 5 0.0112
57 NEONATAL HYPOTENSION 4 0.0109
58 DISTRIBUTIVE SHOCK 24 0.0106
59 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
60 NODAL ARRHYTHMIA 9 0.0105
61 COAGULATION TEST ABNORMAL 8 0.0104
62 CONGENITAL PULMONARY HYPERTENSION 2 0.0104
63 RED BLOOD CELLS URINE POSITIVE 10 0.0103
64 ACINETOBACTER TEST POSITIVE 2 0.0103
65 BLOOD PH DECREASED 17 0.0099
66 NECROTISING ENTEROCOLITIS NEONATAL 4 0.0099
67 DYSBIOSIS 8 0.0097
68 PULMONARY CALCIFICATION 4 0.0097
69 VENTRICULAR FAILURE 3 0.0096
70 CANDIDA TEST POSITIVE 4 0.0096
71 BLOOD BICARBONATE DECREASED 17 0.0090
72 JUGULAR VEIN DISTENSION 5 0.0088
73 ISCHAEMIC HEPATITIS 12 0.0088
74 PLEOCYTOSIS 5 0.0086
75 TRACHEAL HAEMORRHAGE 3 0.0085
76 PROPOFOL INFUSION SYNDROME 6 0.0085
77 DIABETES INSIPIDUS 20 0.0083
78 PORTAL VENOUS GAS 3 0.0083
79 NEONATAL RESPIRATORY FAILURE 4 0.0079
80 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 3 0.0078
81 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 3 0.0077
82 HYPOPERFUSION 8 0.0076
83 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
84 NEONATAL HYPOXIA 6 0.0073
85 BRADYCARDIA NEONATAL 9 0.0072
86 SKIN SENSITISATION 7 0.0068
87 CARDIOGENIC SHOCK 97 0.0068
88 HEART SOUNDS ABNORMAL 5 0.0067
89 OXYGEN SATURATION ABNORMAL 18 0.0063
90 ANAEMIA NEONATAL 3 0.0062
91 DEFECT CONDUCTION INTRAVENTRICULAR 2 0.0062
92 SEPSIS NEONATAL 5 0.0062
93 HYPERMAGNESAEMIA 4 0.0061
94 RIGHT ATRIAL DILATATION 3 0.0059
95 HEPATOSPLENOMEGALY 15 0.0058
96 NECROTISING MYOSITIS 5 0.0058
97 SKIN CANDIDA 3 0.0057
98 MYOGLOBINURIA 3 0.0056
99 DELAYED GRAFT FUNCTION 4 0.0056
100 SYMPTOM MASKED 4 0.0055
101 VASOSPASM 5 0.0054
102 CARDIAC HYPERTROPHY 6 0.0054
103 SERRATIA INFECTION 4 0.0054
104 INTRAVASCULAR HAEMOLYSIS 3 0.0054
105 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 3 0.0053
106 MOTOR DEVELOPMENTAL DELAY 3 0.0052
107 ACUTE PRERENAL FAILURE 6 0.0052
108 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
109 CLONUS 14 0.0051
110 DEATH NEONATAL 7 0.0050
111 PERICARDIAL HAEMORRHAGE 11 0.0050
112 DIAPHRAGMATIC PARALYSIS 3 0.0050
113 HEPATORENAL FAILURE 3 0.0050
114 HAEMODYNAMIC INSTABILITY 38 0.0050
115 PERSISTENT FOETAL CIRCULATION 3 0.0049
116 TROPONIN I INCREASED 8 0.0048
117 ABDOMINAL COMPARTMENT SYNDROME 3 0.0047
118 HEPATIC HAEMORRHAGE 4 0.0047
119 ACINETOBACTER INFECTION 5 0.0046
120 ANAEMIA MEGALOBLASTIC 2 0.0045
121 RIGHT VENTRICULAR HYPERTROPHY 4 0.0044
122 ELECTROENCEPHALOGRAM ABNORMAL 14 0.0044
123 OLIGURIA 27 0.0043
124 ANURIA 37 0.0043
125 ANAL HAEMORRHAGE 12 0.0043
126 VASOPLEGIA SYNDROME 7 0.0043
127 VENTRICULAR FIBRILLATION 47 0.0042
128 ACUTE LUNG INJURY 5 0.0042
129 MYOCARDIAL NECROSIS MARKER INCREASED 7 0.0042
130 TELANGIECTASIA 4 0.0041
131 HYPERLACTACIDAEMIA 11 0.0041
132 DRUG-DISEASE INTERACTION 3 0.0041
133 MATERNAL EXPOSURE DURING DELIVERY 4 0.0040
134 BRAIN HERNIATION 12 0.0040
135 PULMONARY HAEMORRHAGE 31 0.0040
136 NECROTISING COLITIS 5 0.0039
137 SHOCK 89 0.0039
138 LIVEDO RETICULARIS 8 0.0038
139 LABORATORY TEST INTERFERENCE 3 0.0038
140 MULTI-ORGAN FAILURE 66 0.0038
141 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
142 ENTEROCOCCAL BACTERAEMIA 4 0.0038
143 ELECTROMECHANICAL DISSOCIATION 3 0.0038
144 THYROID HORMONES DECREASED 3 0.0037
145 BRONCHOPULMONARY DYSPLASIA 3 0.0037
146 SPUTUM CULTURE POSITIVE 3 0.0037
147 RESPIRATORY ALKALOSIS 6 0.0037
148 PERITONEAL DIALYSIS 3 0.0036
149 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11 0.0036
150 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
151 BLOOD PH INCREASED 2 0.0036
152 STRESS CARDIOMYOPATHY 21 0.0036
153 PERITONEAL HAEMORRHAGE 5 0.0036
154 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
155 BRAIN SCAN ABNORMAL 2 0.0036
156 VENTRICULAR TACHYCARDIA 59 0.0036
157 BRAIN DEATH 11 0.0036
158 MYOCARDIAL INJURY 4 0.0036
159 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
160 PROCEDURAL HYPOTENSION 3 0.0035
161 AORTIC THROMBOSIS 4 0.0035
162 RENAL INFARCT 5 0.0035
163 METHAEMOGLOBINAEMIA 8 0.0035
164 PERIPHERAL ISCHAEMIA 14 0.0034
165 NODAL RHYTHM 5 0.0034
166 RED MAN SYNDROME 3 0.0034
167 HYPERCAPNIA 10 0.0033
168 TORSADE DE POINTES 26 0.0033
169 SINUS ARREST 5 0.0032
170 HEPATIC CONGESTION 3 0.0032
171 INHIBITORY DRUG INTERACTION 5 0.0032
172 ACIDOSIS 24 0.0031
173 LEFT ATRIAL DILATATION 4 0.0031
174 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
175 PCO2 DECREASED 3 0.0031
176 CARDIAC VENTRICULAR THROMBOSIS 4 0.0031
177 METABOLIC ACIDOSIS 99 0.0031
178 RESPIRATORY DISORDER NEONATAL 5 0.0031
179 FOETAL DEATH 16 0.0031
180 MULTIPLE ORGAN DYSFUNCTION SYNDROME 87 0.0031
181 HEPARIN-INDUCED THROMBOCYTOPENIA 15 0.0030
182 VENTRICULAR ARRHYTHMIA 11 0.0030
183 BILIRUBIN CONJUGATED INCREASED 7 0.0030
184 ANION GAP INCREASED 4 0.0030
185 BRAIN HYPOXIA 3 0.0030
186 HYPOGONADISM 3 0.0030
187 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 15 0.0029
188 SPLENIC INFARCTION 5 0.0029
189 DILATATION VENTRICULAR 6 0.0029
190 RIGHT VENTRICULAR FAILURE 20 0.0029
191 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0028
192 PERIPHERAL ARTERY THROMBOSIS 4 0.0028
193 PERIPHERAL ARTERY OCCLUSION 4 0.0028
194 ATRIOVENTRICULAR BLOCK COMPLETE 19 0.0028
195 RETROPERITONEAL HAEMORRHAGE 7 0.0028
196 VASCULAR CALCIFICATION 3 0.0028
197 STUPOR 9 0.0028
198 LABYRINTHITIS 7 0.0028
199 COMA SCALE ABNORMAL 8 0.0028
200 AORTIC VALVE SCLEROSIS 2 0.0027
201 RIGHT VENTRICULAR DYSFUNCTION 3 0.0027
202 PNEUMOPERITONEUM 5 0.0027
203 SINUS BRADYCARDIA 26 0.0027
204 KLEBSIELLA SEPSIS 3 0.0027
205 GANGRENE 16 0.0027
206 COMPLICATIONS OF TRANSPLANTED KIDNEY 6 0.0026
207 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
208 BLOOD UREA INCREASED 44 0.0026
209 CEREBRAL VENTRICLE DILATATION 3 0.0026
210 PULMONARY HYPERTENSION 54 0.0026
211 DIASTOLIC DYSFUNCTION 8 0.0026
212 CARDIOPULMONARY FAILURE 10 0.0026
213 HYPOTONIA NEONATAL 4 0.0026
214 PROCALCITONIN INCREASED 3 0.0026
215 RESPIRATORY ACIDOSIS 10 0.0025
216 BLOOD FIBRINOGEN INCREASED 2 0.0025
217 ESCHERICHIA TEST POSITIVE 3 0.0025
218 VENTRICULAR HYPOKINESIA 8 0.0025
219 CARDIOVASCULAR INSUFFICIENCY 4 0.0025
220 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
221 INFLAMMATORY MARKER INCREASED 12 0.0024
222 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
223 HAEMOTHORAX 7 0.0024
224 URINE OUTPUT DECREASED 21 0.0024
225 ENTEROBACTER INFECTION 4 0.0024
226 NEPHROGENIC ANAEMIA 11 0.0024
227 FOETAL DISTRESS SYNDROME 5 0.0024
228 NEUTROPHIL COUNT INCREASED 24 0.0023
229 PLATELET TRANSFUSION 3 0.0023
230 CARDIAC TAMPONADE 11 0.0023
231 VENTRICULAR DYSFUNCTION 6 0.0023
232 DRUG CLEARANCE DECREASED 3 0.0023
233 HYPOVOLAEMIC SHOCK 11 0.0023
234 CARDIOACTIVE DRUG LEVEL INCREASED 3 0.0023
235 ISCHAEMIC CARDIOMYOPATHY 7 0.0023
236 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
237 AORTIC VALVE STENOSIS 4 0.0022
238 HYPOVOLAEMIA 13 0.0022
239 BRADYCARDIA 117 0.0022
240 CULTURE URINE POSITIVE 3 0.0021
241 DISSEMINATED INTRAVASCULAR COAGULATION 30 0.0021
242 SINUS TACHYCARDIA 30 0.0021
243 DELAYED RECOVERY FROM ANAESTHESIA 2 0.0021
244 CARDIAC ARREST 174 0.0021
245 COAGULOPATHY 35 0.0021
246 COR PULMONALE 2 0.0021
247 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
248 ARTERIAL DISORDER 4 0.0021
249 BLOOD LACTIC ACID INCREASED 11 0.0021
250 BLOOD MAGNESIUM DECREASED 18 0.0021
251 HYPOREFLEXIA 4 0.0021
252 RENAL FAILURE CHRONIC 16 0.0021
253 ARTERIAL THROMBOSIS 4 0.0021
254 RENAL INJURY 61 0.0021
255 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
256 HYPERBILIRUBINAEMIA 21 0.0020
257 LOW BIRTH WEIGHT BABY 16 0.0020
258 LACTIC ACIDOSIS 65 0.0020
259 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
260 TACHYARRHYTHMIA 5 0.0020
261 HYPERPARATHYROIDISM SECONDARY 5 0.0020
262 RENAL HAEMORRHAGE 4 0.0020
263 VASCULAR STENT THROMBOSIS 4 0.0020
264 MYOCARDIAL ISCHAEMIA 22 0.0019
265 ACUTE RESPIRATORY FAILURE 37 0.0019
266 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
267 ASTERIXIS 2 0.0019
268 RESPIRATORY DEPRESSION 23 0.0019
269 ANTICONVULSANT DRUG LEVEL INCREASED 3 0.0019
270 HEPATIC NECROSIS 7 0.0019
271 PULMONARY ARTERIAL PRESSURE INCREASED 3 0.0018
272 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
273 RENAL TUBULAR NECROSIS 18 0.0018
274 VENTRICULAR EXTRASYSTOLES 19 0.0018
275 COLONIC POLYP 3 0.0018
276 RETROPERITONEAL HAEMATOMA 4 0.0018
277 VENA CAVA THROMBOSIS 3 0.0018
278 PROTEIN URINE PRESENT 9 0.0018
279 CARDIAC FAILURE ACUTE 12 0.0018
280 CATHETER SITE DISCHARGE 2 0.0018
281 FEAR OF DEATH 4 0.0018
282 GENERALISED OEDEMA 22 0.0018
283 BLOOD ALBUMIN DECREASED 14 0.0018
284 CIRCULATORY COLLAPSE 30 0.0018
285 FEAR 47 0.0017
286 ARTERIOSPASM CORONARY 7 0.0017
287 TRIGEMINAL NEURALGIA 7 0.0017
288 ISCHAEMIA 8 0.0017
289 HYPOTENSION 347 0.0017
290 INFUSION SITE INFECTION 4 0.0017
291 EXTREMITY NECROSIS 3 0.0017
292 PARTIAL SEIZURES 9 0.0017
293 BREAST CYST 3 0.0017
294 BLOOD CALCIUM DECREASED 19 0.0017
295 JUGULAR VEIN THROMBOSIS 3 0.0017
296 STATUS EPILEPTICUS 19 0.0017
297 CREPITATIONS 5 0.0017
298 PROTHROMBIN TIME PROLONGED 10 0.0017
299 CHRONIC RESPIRATORY FAILURE 2 0.0017
300 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
301 HYPOXIA 58 0.0016
302 POOR PERIPHERAL CIRCULATION 7 0.0016
303 LYMPHOCYTE COUNT DECREASED 29 0.0016
304 ACUTE RESPIRATORY DISTRESS SYNDROME 29 0.0016
305 CALCIPHYLAXIS 3 0.0016
306 PNEUMONIA KLEBSIELLA 3 0.0016
307 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
308 PUPILLARY REFLEX IMPAIRED 3 0.0016
309 AMPUTATION 2 0.0016
310 SEPTIC SHOCK 69 0.0016
311 KLEBSIELLA INFECTION 8 0.0016
312 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
313 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
314 BLOOD CHLORIDE DECREASED 4 0.0015
315 SKIN NECROSIS 8 0.0015
316 VENOUS THROMBOSIS 6 0.0015
317 PULMONARY CONGESTION 20 0.0015
318 THERAPY NON-RESPONDER 68 0.0015
319 EXPOSURE VIA BREAST MILK 6 0.0015
320 MITRAL VALVE INCOMPETENCE 17 0.0015
321 THERAPEUTIC AGENT TOXICITY 5 0.0015
322 AREFLEXIA 4 0.0015
323 BRADYPNOEA 4 0.0015
324 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
325 HICCUPS 12 0.0015
326 HYPERURICAEMIA 6 0.0015
327 ESCHERICHIA INFECTION 12 0.0015
328 RESPIRATORY FAILURE 106 0.0015
329 CAPILLARY LEAK SYNDROME 3 0.0014
330 FLUID OVERLOAD 21 0.0014
331 ATRIAL TACHYCARDIA 3 0.0014
332 ATRIOVENTRICULAR BLOCK 11 0.0014
333 CARDIOMYOPATHY 21 0.0014
334 STAPHYLOCOCCAL SEPSIS 7 0.0014
335 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
336 CARDIO-RESPIRATORY ARREST 59 0.0014
337 AORTIC VALVE INCOMPETENCE 6 0.0014
338 FIBRIN D DIMER INCREASED 5 0.0014
339 HYPERNATRAEMIA 7 0.0014
340 CEREBELLAR HAEMORRHAGE 2 0.0014
341 DUODENAL ULCER HAEMORRHAGE 4 0.0014
342 HYPERPHOSPHATAEMIA 3 0.0014
343 PULMONARY OEDEMA 62 0.0014
344 GASTROINTESTINAL NECROSIS 4 0.0014
345 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
346 CALCINOSIS 3 0.0013
347 ANHEDONIA 35 0.0013
348 TACHYPNOEA 18 0.0013
349 KOUNIS SYNDROME 3 0.0013
350 ECCHYMOSIS 9 0.0013
351 BLOOD PRESSURE IMMEASURABLE 2 0.0013
352 PANCREATITIS NECROTISING 3 0.0013
353 RENAL FAILURE ACUTE 55 0.0013
354 INTESTINAL ISCHAEMIA 7 0.0013
355 PANCREATITIS CHRONIC 3 0.0013
356 PATENT DUCTUS ARTERIOSUS 5 0.0013
357 ORTHOPNOEA 4 0.0013
358 ENTEROCOCCAL INFECTION 6 0.0012
359 RENAL FAILURE 164 0.0012
360 ACUTE KIDNEY INJURY 189 0.0012
361 BACTERIAL SEPSIS 4 0.0012
362 BRADYARRHYTHMIA 2 0.0012
363 LEUKOCYTOSIS 22 0.0012
364 CATHETER SITE HAEMORRHAGE 3 0.0012
365 RESPIRATORY DISTRESS 33 0.0012
366 HAEMODIALYSIS 10 0.0012
367 VASODILATATION 3 0.0012
368 BRAIN OEDEMA 15 0.0012
369 HAEMOLYSIS 9 0.0012
370 LEFT VENTRICULAR FAILURE 4 0.0012
371 CERVICAL SPINAL STENOSIS 2 0.0012
372 BLOOD CHLORIDE INCREASED 2 0.0012
373 HYPOALBUMINAEMIA 9 0.0012
374 HYPOPNOEA 4 0.0012
375 RENAL IMPAIRMENT 96 0.0011
376 EXFOLIATIVE RASH 3 0.0011
377 CARDIAC FAILURE 91 0.0011
378 TRICUSPID VALVE INCOMPETENCE 9 0.0011
379 INFUSION SITE EXTRAVASATION 7 0.0011
380 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
381 BODY TEMPERATURE DECREASED 11 0.0011
382 ENCEPHALOPATHY 27 0.0011
383 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
384 BRAIN INJURY 11 0.0011
385 SUBDURAL HAEMORRHAGE 3 0.0011
386 BACTERAEMIA 13 0.0011
387 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60 0.0011
388 CONDUCTION DISORDER 2 0.0011
389 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
390 HYPOTHERMIA 11 0.0011
391 ELECTROCARDIOGRAM QT PROLONGED 39 0.0011
392 AMYLASE INCREASED 4 0.0011
393 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
394 HYPERKALAEMIA 38 0.0011
395 ON AND OFF PHENOMENON 6 0.0011
396 FREEZING PHENOMENON 4 0.0011
397 CARDIOMEGALY 13 0.0011
398 PNEUMATOSIS INTESTINALIS 3 0.0011
399 PULSE ABSENT 5 0.0011
400 MENINGITIS 7 0.0010
401 INTENTIONAL OVERDOSE 67 0.0010
402 DYSPNOEA AT REST 3 0.0010
403 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
404 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
405 ABDOMINAL WALL HAEMATOMA 2 0.0010
406 PERIPHERAL COLDNESS 14 0.0010
407 SEPSIS 113 0.0010
408 HEPATITIS FULMINANT 3 0.0010
409 ORGANISING PNEUMONIA 5 0.0010
410 UNRESPONSIVE TO STIMULI 26 0.0010
411 CEREBRAL ATROPHY 4 0.0010
412 URINE ANALYSIS ABNORMAL 3 0.0010
413 ATRIAL FLUTTER 8 0.0010
414 BLOOD CULTURE POSITIVE 3 0.0010
415 METABOLIC ENCEPHALOPATHY 3 0.0010
416 PREMATURE BABY 30 0.0010
417 CEREBROVASCULAR DISORDER 3 0.0010
418 HEPATIC FAILURE 30 0.0010
419 ORGAN FAILURE 4 0.0010
420 EXTRAVASATION 4 0.0010
421 ATRIAL THROMBOSIS 2 0.0010
422 COMA 46 0.0010
423 BLOOD PRESSURE DECREASED 64 0.0010
424 GASTROINTESTINAL PERFORATION 4 0.0010
425 MULTIPLE INJURIES 6 0.0010
426 BUNDLE BRANCH BLOCK LEFT 4 0.0009
427 HAEMORRHAGE INTRACRANIAL 14 0.0009
428 MYDRIASIS 12 0.0009
429 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
430 HYPERGLYCAEMIA 34 0.0009
431 PORTAL VEIN THROMBOSIS 3 0.0009
432 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
433 NORMAL NEWBORN 5 0.0009
434 ASCITES 27 0.0009
435 HEPATOMEGALY 9 0.0009
436 THROMBOSIS IN DEVICE 3 0.0009
437 OTITIS MEDIA 3 0.0009
438 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
439 OLIGOHYDRAMNIOS 3 0.0009
440 BACTERIAL TEST POSITIVE 2 0.0009
441 ACUTE PULMONARY OEDEMA 5 0.0009
442 CLOSTRIDIAL INFECTION 3 0.0009
443 HEPATIC FIBROSIS 3 0.0009
444 EXERCISE TOLERANCE DECREASED 5 0.0009
445 UROSEPSIS 8 0.0009
446 MENTAL STATUS CHANGES 24 0.0009
447 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
448 PLEURAL EFFUSION 52 0.0009
449 NECROTISING FASCIITIS 3 0.0009
450 PULMONARY TOXICITY 6 0.0008
451 DIVERTICULUM 6 0.0008
452 INJURY 59 0.0008
453 EJECTION FRACTION DECREASED 13 0.0008
454 KIDNEY TRANSPLANT REJECTION 4 0.0008
455 ATELECTASIS 8 0.0008
456 PREMATURE DELIVERY 13 0.0008
457 PSEUDOMONAS INFECTION 7 0.0008
458 HYPERVOLAEMIA 4 0.0008
459 CARDIAC MURMUR 7 0.0008
460 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
461 ACUTE HEPATIC FAILURE 11 0.0008
462 HYPOKALAEMIA 37 0.0008
463 HYDRONEPHROSIS 6 0.0008
464 HYPERAMMONAEMIA 4 0.0008
465 CORONARY ARTERY STENOSIS 4 0.0008
466 RHABDOMYOLYSIS 33 0.0008
467 HYPOMAGNESAEMIA 11 0.0008
468 TROPONIN INCREASED 6 0.0008
469 DYSLIPIDAEMIA 4 0.0008
470 ENDOCARDITIS 4 0.0008
471 COMPARTMENT SYNDROME 2 0.0008
472 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
473 TOXICITY TO VARIOUS AGENTS 129 0.0008
474 BLOOD CREATININE INCREASED 49 0.0007
475 ANAESTHETIC COMPLICATION 2 0.0007
476 ADRENAL INSUFFICIENCY 9 0.0007
477 POSTOPERATIVE WOUND INFECTION 5 0.0007
478 UNEVALUABLE EVENT 56 0.0007
479 SPUTUM DISCOLOURED 7 0.0007
480 SHOCK HAEMORRHAGIC 6 0.0007
481 HYDROCEPHALUS 4 0.0007
482 POLYURIA 6 0.0007
483 HEPATIC FUNCTION ABNORMAL 27 0.0007
484 CONGESTIVE CARDIOMYOPATHY 3 0.0007
485 EXTRASYSTOLES 5 0.0007
486 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
487 INTESTINAL PERFORATION 8 0.0007
488 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
489 CARDIAC FAILURE CHRONIC 3 0.0007
490 MYOCARDITIS 8 0.0007
491 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
492 TACHYCARDIA 62 0.0007
493 METABOLIC DISORDER 4 0.0007
494 ELECTROLYTE IMBALANCE 8 0.0007
495 BILIARY COLIC 2 0.0007
496 POST PROCEDURAL HAEMORRHAGE 8 0.0007
497 C-REACTIVE PROTEIN INCREASED 25 0.0007
498 HYPOCALCAEMIA 13 0.0007
499 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
500 LUNG INFILTRATION 6 0.0007
501 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
502 BLOOD POTASSIUM INCREASED 11 0.0007
503 HYPOPHOSPHATAEMIA 5 0.0007
504 HYPERLIPIDAEMIA 8 0.0007
505 DRUG INTERACTION 106 0.0007
506 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
507 END STAGE RENAL DISEASE 12 0.0007
508 HYPERTHERMIA 5 0.0007
509 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
510 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
511 DEVICE RELATED INFECTION 10 0.0006
512 PERICARDIAL EFFUSION 15 0.0006
513 ACUTE MYOCARDIAL INFARCTION 19 0.0006
514 DEMENTIA 18 0.0006
515 HAEMORRHAGIC STROKE 5 0.0006
516 CYANOSIS 10 0.0006
517 FOOT DEFORMITY 7 0.0006
518 PRODUCT PACKAGING ISSUE 6 0.0006
519 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
520 PNEUMOTHORAX 10 0.0006
521 BILE DUCT STONE 2 0.0006
522 FOETAL EXPOSURE DURING PREGNANCY 51 0.0006
523 MALNUTRITION 7 0.0006
524 POST PROCEDURAL COMPLICATION 12 0.0006
525 TRANSPLANT REJECTION 5 0.0006
526 PANCREATITIS ACUTE 14 0.0006
527 CARDIAC FAILURE CONGESTIVE 50 0.0006
528 THROMBOCYTOPENIA 68 0.0006
529 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
530 BK VIRUS INFECTION 2 0.0006
531 PATHOLOGICAL FRACTURE 3 0.0006
532 BLOOD IRON DECREASED 7 0.0006
533 BRONCHOPNEUMONIA 2 0.0006
534 FAILURE TO THRIVE 3 0.0006
535 AORTIC STENOSIS 2 0.0006
536 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
537 CARDIOTOXICITY 5 0.0006
538 SUBDURAL HAEMATOMA 8 0.0006
539 GOUT 10 0.0006
540 HAEMATOCRIT DECREASED 11 0.0006
541 MOUTH HAEMORRHAGE 4 0.0005
542 ATRIAL FIBRILLATION 53 0.0005
543 RESPIRATORY ARREST 15 0.0005
544 NECROSIS 3 0.0005
545 ANGIOPATHY 3 0.0005
546 NEPHROPATHY TOXIC 6 0.0005
547 OXYGEN SATURATION DECREASED 30 0.0005
548 CHOLECYSTITIS ACUTE 3 0.0005
549 NEUTROPHILIA 3 0.0005
550 NEUROLOGICAL SYMPTOM 3 0.0005
551 HYPERTONIA 3 0.0005
552 COMMUNICATION DISORDER 2 0.0005
553 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
554 CHOLESTASIS 10 0.0005
555 BLOOD URIC ACID INCREASED 3 0.0005
556 RALES 3 0.0005
557 APNOEA 4 0.0005
558 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
559 PLEURISY 3 0.0005
560 SEIZURE 58 0.0005
561 AZOTAEMIA 2 0.0005
562 CANDIDIASIS 2 0.0005
563 DIALYSIS 7 0.0005
564 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
565 CEREBRAL INFARCTION 12 0.0005
566 SUBARACHNOID HAEMORRHAGE 5 0.0005
567 SCOLIOSIS 3 0.0005
568 HEART RATE DECREASED 17 0.0005
569 DRUG LEVEL INCREASED 8 0.0005
570 AORTIC DISSECTION 2 0.0005
571 ACUTE CORONARY SYNDROME 4 0.0005
572 SUICIDE ATTEMPT 29 0.0005
573 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
574 HALLUCINATION, VISUAL 10 0.0005
575 SEROTONIN SYNDROME 9 0.0005
576 EPISTAXIS 35 0.0005
577 HAEMOGLOBIN DECREASED 48 0.0005
578 ANAPHYLACTIC SHOCK 12 0.0005
579 HAEMATOMA 12 0.0005
580 HYPONATRAEMIA 26 0.0005
581 TUMOUR LYSIS SYNDROME 4 0.0005
582 ABDOMINAL ABSCESS 2 0.0005
583 TRANSAMINASES INCREASED 10 0.0004
584 GENERAL PHYSICAL HEALTH DETERIORATION 52 0.0004
585 HEPATOTOXICITY 10 0.0004
586 ISCHAEMIC STROKE 8 0.0004
587 LIVER INJURY 11 0.0004
588 CONDITION AGGRAVATED 136 0.0004
589 LIVER FUNCTION TEST ABNORMAL 13 0.0004
590 CEREBRAL HAEMORRHAGE 16 0.0004
591 OEDEMA 24 0.0004
592 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
593 ABDOMINAL DISTENSION 46 0.0004
594 SCIATICA 7 0.0004
595 DRUG INEFFECTIVE 575 0.0004
596 CHRONIC KIDNEY DISEASE 33 0.0004
597 GRAND MAL CONVULSION 4 0.0004
598 SPLENOMEGALY 5 0.0004
599 ARRHYTHMIA 20 0.0004
600 NEUTROPENIC SEPSIS 3 0.0004
601 CHOLECYSTITIS 5 0.0004
602 ANAEMIA 80 0.0004
603 DYSKINESIA 17 0.0004
604 MUSCLE RIGIDITY 5 0.0004
605 GRAFT VERSUS HOST DISEASE 3 0.0004
606 DERMATITIS BULLOUS 3 0.0004
607 THROMBOTIC MICROANGIOPATHY 4 0.0004
608 MELAENA 9 0.0004
609 HAEMATURIA 14 0.0004
610 BLOOD BILIRUBIN INCREASED 11 0.0004
611 STEVENS-JOHNSON SYNDROME 9 0.0004
612 RASH MACULO-PAPULAR 9 0.0004
613 ANEURYSM 2 0.0004
614 RESPIRATORY DISORDER 12 0.0004
615 LETHARGY 23 0.0004
616 DERMATITIS EXFOLIATIVE 2 0.0004
617 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
618 CARDIOVASCULAR DISORDER 10 0.0004
619 BONE MARROW FAILURE 8 0.0004
620 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
621 BODY TEMPERATURE INCREASED 8 0.0004
622 CACHEXIA 2 0.0004
623 CEREBRAL ISCHAEMIA 2 0.0004
624 CONGENITAL ANOMALY 3 0.0004
625 PERITONITIS 8 0.0004
626 EXPOSURE DURING PREGNANCY 24 0.0004
627 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
628 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
629 PULMONARY EMBOLISM 36 0.0004
630 DISORIENTATION 15 0.0004
631 BACTERIAL INFECTION 7 0.0004
632 THROMBOSIS 30 0.0004
633 DECREASED ACTIVITY 4 0.0004
634 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
635 ASPIRATION 4 0.0004
636 EMOTIONAL DISTRESS 44 0.0004
637 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
638 HEMIPLEGIA 3 0.0004
639 EOSINOPHIL COUNT INCREASED 3 0.0004
640 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
641 DEEP VEIN THROMBOSIS 23 0.0004
642 DRUG RESISTANCE 9 0.0004
643 CYTOKINE RELEASE SYNDROME 7 0.0003
644 TREATMENT NONCOMPLIANCE 19 0.0003
645 HYPERTHYROIDISM 5 0.0003
646 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
647 CAESAREAN SECTION 4 0.0003
648 GASTRITIS 9 0.0003
649 GROIN PAIN 3 0.0003
650 DECREASED INTEREST 2 0.0003
651 PURPURA 3 0.0003
652 LOSS OF CONSCIOUSNESS 43 0.0003
653 CHOLELITHIASIS 11 0.0003
654 STAPHYLOCOCCAL INFECTION 11 0.0003
655 CORONARY ARTERY DISEASE 10 0.0003
656 PATHOGEN RESISTANCE 3 0.0003
657 PLATELET COUNT DECREASED 35 0.0003
658 PNEUMONIA BACTERIAL 3 0.0003
659 OVERDOSE 70 0.0003
660 HYPERCALCAEMIA 4 0.0003
661 PERSONALITY CHANGE 3 0.0003
662 CHOLANGITIS 2 0.0003
663 DELUSION 5 0.0003
664 HEPATIC ENCEPHALOPATHY 3 0.0003
665 COGNITIVE DISORDER 15 0.0003
666 DIARRHOEA HAEMORRHAGIC 3 0.0003
667 INTESTINAL OBSTRUCTION 12 0.0003
668 DELIRIUM 11 0.0003
669 BLOOD URINE PRESENT 6 0.0003
670 PROTEINURIA 6 0.0003
671 HYPOTHYROIDISM 10 0.0003
672 PNEUMONIA 101 0.0003
673 BRADYPHRENIA 2 0.0003
674 ASPERGILLUS INFECTION 2 0.0003
675 DISABILITY 6 0.0003
676 PANCREATITIS 16 0.0003
677 HYPERTENSION 64 0.0003
678 OFF LABEL USE 264 0.0003
679 HYPOTONIA 3 0.0003
680 SALIVARY HYPERSECRETION 3 0.0003
681 BLOOD POTASSIUM DECREASED 9 0.0003
682 CHOLECYSTITIS CHRONIC 2 0.0003
683 COLITIS ISCHAEMIC 2 0.0003
684 DISEASE PROGRESSION 35 0.0003
685 LIMB INJURY 8 0.0003
686 PALLOR 8 0.0003
687 NERVOUS SYSTEM DISORDER 9 0.0003
688 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
689 LYMPHOPENIA 4 0.0003
690 DRUG ERUPTION 5 0.0003
691 PYREXIA 97 0.0003
692 HEREDITARY ANGIOEDEMA 3 0.0003
693 TREATMENT FAILURE 23 0.0003
694 HAEMATEMESIS 7 0.0003
695 HYPOKINESIA 4 0.0003
696 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
697 FEBRILE NEUTROPENIA 18 0.0003
698 PSYCHOTIC DISORDER 8 0.0003
699 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
700 CEREBRAL DISORDER 2 0.0003
701 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
702 HYPERTENSIVE CRISIS 3 0.0003
703 CONJUNCTIVITIS 5 0.0003
704 HAEMORRHAGE 28 0.0003
705 HEART RATE IRREGULAR 6 0.0003
706 REBOUND EFFECT 3 0.0003
707 ECONOMIC PROBLEM 4 0.0003
708 CHOLECYSTECTOMY 3 0.0003
709 OEDEMA PERIPHERAL 32 0.0003
710 CONVULSION 15 0.0003
711 GASTRIC HAEMORRHAGE 3 0.0003
712 PRESCRIBED OVERDOSE 5 0.0003
713 CELLULITIS 13 0.0003
714 LUNG INFECTION 4 0.0003
715 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
716 COVID-19 PNEUMONIA 3 0.0003
717 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
718 MYOCARDIAL INFARCTION 44 0.0003
719 HAEMOPTYSIS 7 0.0003
720 PANCYTOPENIA 14 0.0003
721 MYELOSUPPRESSION 9 0.0002
722 MENTAL IMPAIRMENT 6 0.0002
723 HYPOGLYCAEMIA 12 0.0002
724 TASTE DISORDER 5 0.0002
725 ANXIETY 70 0.0002
726 RESTLESSNESS 9 0.0002
727 DECUBITUS ULCER 2 0.0002
728 METASTASES TO BONE 4 0.0002
729 PHARYNGITIS 3 0.0002
730 ILEUS 3 0.0002
731 NEEDLE ISSUE 7 0.0002
732 PNEUMONIA ASPIRATION 6 0.0002
733 HALLUCINATION 18 0.0002
734 ATRIAL SEPTAL DEFECT 2 0.0002
735 FACE OEDEMA 4 0.0002
736 MUSCLE ATROPHY 3 0.0002
737 URINARY INCONTINENCE 7 0.0002
738 HEMIPARESIS 4 0.0002
739 PRODUCT USE ISSUE 44 0.0002
740 BLOOD GLUCOSE INCREASED 44 0.0002
741 CARDIAC OPERATION 2 0.0002
742 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
743 PRODUCTIVE COUGH 11 0.0002
744 ORTHOSTATIC HYPOTENSION 4 0.0002
745 MUSCULOSKELETAL STIFFNESS 20 0.0002
746 NEUROTOXICITY 4 0.0002
747 CARDIAC DISORDER 21 0.0002
748 DEVELOPMENTAL DELAY 2 0.0002
749 OSTEOMYELITIS 4 0.0002
750 DRUG TOXICITY 3 0.0002
751 SKIN DISCOLOURATION 10 0.0002
752 COORDINATION ABNORMAL 3 0.0002
753 HEPATIC STEATOSIS 4 0.0002
754 DEVICE OCCLUSION 3 0.0002
755 ARTERIOSCLEROSIS 2 0.0002
756 OSTEOARTHRITIS 9 0.0002
757 BLOOD SODIUM DECREASED 4 0.0002
758 CONFUSIONAL STATE 34 0.0002
759 BRONCHOSPASM 3 0.0002
760 PARALYSIS 3 0.0002
761 RECTAL HAEMORRHAGE 9 0.0002
762 BLOOD PRESSURE FLUCTUATION 5 0.0002
763 AGITATION 15 0.0002
764 LIVER DISORDER 9 0.0002
765 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
766 DYSPNOEA 114 0.0002
767 BLOOD PRESSURE ABNORMAL 4 0.0002
768 LEUKOPENIA 10 0.0002
769 SYNCOPE 20 0.0002
770 URINARY TRACT INFECTION 34 0.0002
771 MEDICATION ERROR 11 0.0002
772 ABDOMINAL PAIN 46 0.0002
773 DRUG ADMINISTRATION ERROR 6 0.0002
774 HEPATITIS 5 0.0002
775 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
776 MUSCULAR WEAKNESS 22 0.0002
777 RENAL DISORDER 9 0.0002
778 ACUTE MYELOID LEUKAEMIA 3 0.0002
779 COMPLETED SUICIDE 16 0.0002
780 VOMITING 90 0.0002
781 DRUG-INDUCED LIVER INJURY 6 0.0002
782 DERMATITIS 4 0.0002
783 JOINT STIFFNESS 5 0.0002
784 DEHYDRATION 25 0.0002
785 MOVEMENT DISORDER 6 0.0002
786 FAECES DISCOLOURED 4 0.0002
787 PNEUMONITIS 5 0.0002
788 MOBILITY DECREASED 13 0.0002
789 PERICARDITIS 3 0.0002
790 ASTHENIA 67 0.0002
791 CANDIDA INFECTION 3 0.0002
792 ANGINA PECTORIS 5 0.0002
793 PARANOIA 3 0.0002
794 CHEST PAIN 32 0.0002
795 NEUTROPHIL COUNT DECREASED 7 0.0002
796 DEPRESSION 39 0.0002
797 EOSINOPHILIA 3 0.0002
798 HYPERHIDROSIS 22 0.0002
799 METASTASES TO LIVER 3 0.0002
800 DIABETES MELLITUS 13 0.0002
801 WHEEZING 10 0.0002
802 APHASIA 5 0.0002
803 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
804 DIARRHOEA 106 0.0002
805 FEELING HOT 10 0.0002
806 HYPOACUSIS 7 0.0002
807 CHILLS 19 0.0002
808 GAIT DISTURBANCE 31 0.0002
809 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
810 HEPATIC ENZYME INCREASED 11 0.0002
811 FLATULENCE 9 0.0002
812 HEAD INJURY 5 0.0002
813 FLUID RETENTION 8 0.0002
814 HYPOPHAGIA 4 0.0002
815 PULMONARY FIBROSIS 3 0.0002
816 CHEST DISCOMFORT 16 0.0002
817 DRUG PRESCRIBING ERROR 3 0.0002
818 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
819 HIP FRACTURE 5 0.0002
820 RASH GENERALISED 4 0.0002
821 CHOKING 3 0.0002
822 RESPIRATORY TRACT INFECTION 4 0.0002
823 CEREBROVASCULAR ACCIDENT 26 0.0002
824 NERVOUSNESS 8 0.0002
825 PAIN 94 0.0002
826 BEDRIDDEN 2 0.0002
827 ABNORMAL BEHAVIOUR 6 0.0002
828 HEART RATE INCREASED 15 0.0002
829 FALL 50 0.0002
830 URINARY RETENTION 5 0.0001
831 JAUNDICE 4 0.0001
832 TYPE 2 DIABETES MELLITUS 5 0.0001
833 PRODUCT ADMINISTRATION ERROR 3 0.0001
834 STOMATITIS 9 0.0001
835 OCULAR HYPERAEMIA 7 0.0001
836 DEATH 125 0.0001
837 HAEMATOCHEZIA 8 0.0001
838 ANAPHYLACTIC REACTION 8 0.0001
839 FEELING COLD 4 0.0001
840 BLINDNESS UNILATERAL 2 0.0001
841 LYMPHADENOPATHY 5 0.0001
842 PAIN IN JAW 4 0.0001
843 AGGRESSION 7 0.0001
844 LIVER FUNCTION TEST INCREASED 3 0.0001
845 HERPES ZOSTER 8 0.0001
846 MENTAL DISORDER 6 0.0001
847 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
848 DRUG EFFECT INCOMPLETE 5 0.0001
849 PALPITATIONS 16 0.0001
850 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
851 DYSURIA 5 0.0001
852 INFLAMMATION 7 0.0001
853 SOMNOLENCE 27 0.0001
854 SPEECH DISORDER 7 0.0001
855 CHROMATURIA 3 0.0001
856 DYSARTHRIA 5 0.0001
857 DYSPNOEA EXERTIONAL 5 0.0001
858 EPILEPSY 4 0.0001
859 EMOTIONAL DISORDER 4 0.0001
860 SWELLING 12 0.0001
861 DIABETIC KETOACIDOSIS 3 0.0001
862 OSTEONECROSIS OF JAW 3 0.0001
863 CYTOMEGALOVIRUS INFECTION 2 0.0001
864 FUNGAL INFECTION 4 0.0001
865 NEUTROPENIA 16 0.0001
866 INFLUENZA 13 0.0001
867 SKIN ULCER 3 0.0001
868 DIPLOPIA 3 0.0001
869 DISCOMFORT 7 0.0001
870 SEDATION 3 0.0001
871 COLD SWEAT 2 0.0001
872 DECREASED APPETITE 26 0.0001
873 THROAT TIGHTNESS 3 0.0001
874 NAUSEA 87 0.0001
875 BONE DISORDER 2 0.0001
876 PANIC ATTACK 4 0.0001
877 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
878 DRUG ABUSE 9 0.0001
879 AMNESIA 7 0.0001
880 BLISTER 6 0.0001
881 DIZZINESS 52 0.0001
882 INTERSTITIAL LUNG DISEASE 5 0.0001
883 DYSSTASIA 3 0.0001
884 CATARACT 6 0.0001
885 COUGH 28 0.0001
886 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
887 BLINDNESS 4 0.0001
888 LUNG NEOPLASM MALIGNANT 4 0.0001
889 CONSTIPATION 21 0.0001
890 POLLAKIURIA 4 0.0001
891 WITHDRAWAL SYNDROME 4 0.0001
892 DYSPHAGIA 9 0.0001
893 INSOMNIA 25 0.0001
894 DISTURBANCE IN ATTENTION 5 0.0001
895 BALANCE DISORDER 8 0.0001
896 SWELLING FACE 6 0.0001
897 BLOOD PRESSURE INCREASED 14 0.0001
898 VIRAL INFECTION 3 0.0001
899 WEIGHT INCREASED 20 0.0001
900 GASTROINTESTINAL DISORDER 8 0.0001
901 DEVICE ISSUE 8 0.0001
902 THROAT IRRITATION 4 0.0001
903 VISUAL IMPAIRMENT 11 0.0001
904 SINUSITIS 9 0.0001
905 NEPHROLITHIASIS 4 0.0001
906 BLOOD CHOLESTEROL INCREASED 4 0.0001
907 NASAL CONGESTION 5 0.0001
908 DISEASE RECURRENCE 4 0.0001
909 INFECTION 12 0.0001
910 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
911 CRYING 3 0.0001
912 UNDERDOSE 6 0.0001
913 NASOPHARYNGITIS 15 0.0001
914 BRONCHITIS 6 0.0001
915 AGEUSIA 2 0.0001
916 INTENTIONAL PRODUCT MISUSE 7 0.0001
917 TREMOR 13 0.0001
918 ABDOMINAL PAIN UPPER 16 0.0001
919 FATIGUE 60 0.0001
920 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
921 SUICIDAL IDEATION 7 0.0001
922 MUSCULOSKELETAL PAIN 4 0.0001
923 ABORTION SPONTANEOUS 3 0.0001
924 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
925 NEUROPATHY PERIPHERAL 7 0.0001
926 ABNORMAL DREAMS 2 0.0001
927 NECK PAIN 4 0.0001
928 DEVICE MALFUNCTION 5 0.0001
929 SLEEP DISORDER 5 0.0001
930 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
931 VAGINAL HAEMORRHAGE 3 0.0001
932 ERYTHEMA 14 0.0001
933 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
934 NO ADVERSE EVENT 12 0.0001
935 ABDOMINAL DISCOMFORT 11 0.0001
936 TINNITUS 3 0.0001
937 MYALGIA 11 0.0001
938 HYPERSENSITIVITY 12 0.0001
939 PAIN IN EXTREMITY 19 0.0001
940 WEIGHT DECREASED 18 0.0001
941 RASH ERYTHEMATOUS 3 0.0001
942 MULTIPLE SCLEROSIS 3 0.0001
943 COVID-19 11 0.0001
944 FEELING ABNORMAL 15 0.0001
945 RHINORRHOEA 4 0.0001
946 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
947 FLUSHING 6 0.0001
948 MEMORY IMPAIRMENT 8 0.0001
949 PARAESTHESIA 9 0.0001
950 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
951 DEPRESSED MOOD 3 0.0001
952 INJECTION SITE ERYTHEMA 7 0.0001
953 ARTHRALGIA 23 0.0001
954 MALAISE 24 0.0001
955 ADVERSE EVENT 5 0.0001
956 ARTHROPATHY 3 0.0001
957 DYSGEUSIA 4 0.0001
958 RASH 23 0.0001
959 COLITIS 2 0.0001
960 BACK PAIN 12 0.0001
961 HEADACHE 31 0.0000
962 DRY MOUTH 4 0.0000
963 MUSCLE SPASMS 9 0.0000
964 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
965 HYPOAESTHESIA 7 0.0000
966 DEVICE LEAKAGE 2 0.0000
967 DRUG WITHDRAWAL SYNDROME 4 0.0000
968 DEVICE DIFFICULT TO USE 3 0.0000
969 ANGIOEDEMA 2 0.0000
970 ADVERSE DRUG REACTION 4 0.0000
971 ASTHMA 5 0.0000
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
973 THERAPY INTERRUPTED 3 0.0000
974 CONTUSION 4 0.0000
975 DRUG INTOLERANCE 4 0.0000
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
977 ILLNESS 4 0.0000
978 ARTHRITIS 3 0.0000
979 INJECTION SITE HAEMORRHAGE 3 0.0000
980 SKIN EXFOLIATION 3 0.0000
981 BONE PAIN 2 0.0000
982 PRURITUS 13 0.0000
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
984 JOINT SWELLING 4 0.0000
985 PERIPHERAL SWELLING 5 0.0000
986 OROPHARYNGEAL PAIN 3 0.0000
987 MIGRAINE 3 0.0000
988 VISION BLURRED 4 0.0000
989 INCORRECT DOSE ADMINISTERED 6 0.0000
990 HOSPITALISATION 4 0.0000
991 URTICARIA 4 0.0000
992 PRODUCT QUALITY ISSUE 3 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
994 ALOPECIA 2 0.0000